Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hodgson, J. Drug pipeline 3Q23 — ERT, bispecifics and CRISPR in sickle cell disease. Nat Biotechnol 41, 1498–1500 (2023). https://doi.org/10.1038/s41587-023-02015-z
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41587-023-02015-z
- Springer Nature America, Inc.
This article is cited by
-
Advances and challenges of the cell-based therapies among diabetic patients
Journal of Translational Medicine (2024)